drugset / Trial / NCT03655964

Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke

NCT03655964

Phase 2 Completed 60 enrolled Aristotle University Of Thessaloniki
RandomizedParallel-groupSingle-blindTreatment

Summary

Single-blind, randomized, active-treatment controlled clinical study evaluating the effect of omesartan and nebivolol versus no treatment on 24-hour brachial and central aortic blood pressure in hypertensive patients with acute ischemic stroke

Timeline

Start
2018-08-20
Primary completion
2019-08-20
Completion
2019-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Nebivolol Other / unclassified 5 mg
Subject Olmesartan Other / unclassified 20 mg

Indications